Compass Pathways vs CRISPR Therapeutics
Compass Pathways vs CRISPR Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Compass Pathways is on 57/100 and CRISPR Therapeutics on 64/100.
Where each one leads
Compass Pathways
Leads on none of the measures we hold for both companies.
CRISPR Therapeutics
- our overall score: 64/100 against 57/100
- funding raised: $547M against $294M
At a glance
| Measure | Compass Pathways | CRISPR Therapeutics |
|---|---|---|
| What it is | Accelerating patient access to evidence-based innovation in mental health. | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. |
| Category | Biotechnology, Healthcare, Mental Health, Pharmaceuticals | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Services | Platform |
| Founded | 2018 | 2013 |
| Headquarters | London, United Kingdom | Zug, Switzerland |
| Status | Active | Active |
Size, funding and growth
| Measure | Compass Pathways | CRISPR Therapeutics |
|---|---|---|
| Employees | 241 | Not published |
| Total funding | $294M | $547M |
| Latest round | IPO | Series B |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 39,951 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Compass Pathways | CRISPR Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 64/100 |
| Traction | 60/100 | 40/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 31/100 | 13/100 |
| Quality | 68/100 | 88/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | D (44/100) |
| Domain ratingLink authority, 0-100 | 65/100 | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Compass Pathways | CRISPR Therapeutics |
|---|---|---|
| Hosting | AWS | Self Managed |
| CDN | Cloudflare | Not detected |
| Frameworks | Next.js, Tailwind CSS | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Compass Pathways vs CRISPR Therapeutics: common questions
Which is better, Compass Pathways or CRISPR Therapeutics?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Compass Pathways and CRISPR Therapeutics compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 57/100), funding raised ($547M against $294M).
Read the full Compass Pathways review and pricing or the CRISPR Therapeutics review and pricing. You can also browse other Compass Pathways alternatives we track.